Over 450 patients have had the implant for more than two years, and approximately 80 patients have passed five years since surgery. The majority are knee patients (Episealer® Knee), but the company is also executing on its early commercialization of the ankle implant, Episealer® Talus.
The Episealer and instruments are designed to remove damaged tissue as well as restore the area with a perfectly fitting implant. An individualized drill guide is designed to increase the precision of the surgical procedure for optimal implant positioning.
”Our history of strong clinical documentation and a solid operational experience creates a compelling combination for the future. We have satisfied customers, patients and counter-parties in a growing number of geographies, and we know that we are a market leader in a growing segment within orthopaedics,” said Pål Ryfors, CEO of Episurf Medical.
Over 450 patients have had the implant for more than two years, and approximately 80 patients have passed five years since surgery. The majority are knee patients (Episealer® Knee), but the company is also executing on its early commercialization of the ankle implant, Episealer® Talus.
The Episealer and instruments are designed to remove damaged tissue as well as restore the area with a perfectly fitting implant. An individualized drill guide is designed to increase the precision of the surgical procedure for optimal implant positioning.
”Our history of strong clinical documentation and a solid operational experience creates a compelling combination for the future. We have satisfied customers, patients and counter-parties in a growing number of geographies, and we know that we are a market leader in a growing segment within orthopaedics,” said Pål Ryfors, CEO of Episurf Medical.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
